EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Point-of-Care Prediction Tool for Recurrent Tuberculosis

Samyra R Cox iD, Aye Hnin Moe iD, Akshay N Gupte, Abhay Kadam iD, Shahanara Valawalkar iD, Nikhil Gupte, Gayatri Lele iD, Emily A Kendall iD, Charlotte Baillie, Madhu Sudan Barthwal, Arjunlal Kakrani iD, Vidya Mave iD und 2 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Samyra R Cox und 13 weiteren Autor:innen. Beteiligte Einrichtung: International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Tuberculosis, Point-of-Care Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, US National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An estimated 10% of tuberculosis (TB) survivors who recently completed treatment in India develop TB again. We sought to develop a parsimonious model for predicting TB recurrence that can help target post-treatment active case finding among the highest-risk TB survivors.

Methods

The TB Aftermath trial enrolled TB survivors at treatment completion from 6 public TB clinics in Maharashtra, India, and assessed participants at 6-month intervals. Our prediction endpoint was recurrent TB diagnosed within 18 months of treatment completion. Candidate variables included risk factors for recurrence identified a priori and lung function assessments. We used LASSO (Least Absolute Shrinkage and Selection Operator) regression to shortlist predictors and estimated probability of recurrence using logistic regression. We conducted internal validation, assessed discrimination, and plotted calibration. Model selection was based on practical utility and predictive accuracy. For our selected model, we identified a cutoff for achieving 90% sensitivity.

Results

Among 1033 participants, we identified 85 (8.2%) recurrences. Several 5-item models measurable at treatment completion had moderate discrimination. Our selected model included sex, household income, body mass index, peak expiratory flow from spirometry, and history of multiple TB episodes. The selected model had a cross-validated c-statistic of .69 (95% CI: .56–.77) and acceptable calibration (intercept: .03 [95% CI: −.03, .09]; slope: .66 [.08–1.24]). TB survivors with a predicted probability ≥3.7% accounted for 90% of recurrences.

Conclusions

A 5-item tool, measurable at treatment completion, showed moderate predictive accuracy for recurrent TB. At scale, a simple 5-item prediction tool may increase efficiency of post-treatment active case finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisPoint-of-Care SystemsHumansMaleFemaleAdultRecurrenceIndiaMiddle AgedRisk FactorsYoung AdultAntitubercular Agents

Stichwörter der Autor:innen

case-findingpredictionrecurrencescreeningtuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Center for Infectious Diseases in India, Johns Hopkins India, Pune, Maharashtra, India.
  • Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Hospital and Research Centre, Dr. D.Y. Patil Medical College, Pune, Maharashtra, India.

ORCID-Profile: Samyra R Cox, Aye Hnin Moe, Abhay Kadam, Shahanara Valawalkar, Gayatri Lele, Emily A Kendall, Arjunlal Kakrani, Vidya Mave, David W Dowdy

Förderung

  • NIAID NIH HHS
  • US National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Cox, S. R., Moe, A. H., Gupte, A. N., Kadam, A., Valawalkar, S., Gupte, N., Lele, G., Kendall, E. A., Baillie, C., Barthwal, M. S., Kakrani, A., Mave, V., Dowdy, D. W., & Golub, J. E. (2026). A Point-of-Care Prediction Tool for Recurrent Tuberculosis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf353

Vancouver

Cox SR, Moe AH, Gupte AN, Kadam A, Valawalkar S, Gupte N, et al. A Point-of-Care Prediction Tool for Recurrent Tuberculosis. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf353

BibTeX
@article{Cox2026,
  author = {Cox, Samyra R and Moe, Aye Hnin and Gupte, Akshay N and Kadam, Abhay and Valawalkar, Shahanara and Gupte, Nikhil and Lele, Gayatri and Kendall, Emily A and Baillie, Charlotte and Barthwal, Madhu Sudan and Kakrani, Arjunlal and Mave, Vidya and Dowdy, David W and Golub, Jonathan E},
  title = {A Point-of-Care Prediction Tool for Recurrent Tuberculosis},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf353}
}
Kostenlos starten →